Electrochemiluminescence (ECL) is a chemiluminescence phenomenon triggered by electrochemical reactions at the electrode surface, which has gradually become a high-sensitivity detection technology due to its low background, simple instrumentation, and high sensitivity. Therein, potential-resolved ECL refers to the generation of two or more ECL signals with distinct potentials and wavelengths during an electrochemical process. This unique capability enables simultaneous multi-signal outputs, making potential-resolved ECL particularly promising for self-calibration and multiplexed detection strategies. In this review, we focus on two critical aspects: on the one hand, the advancement of traditional ECL luminophores and potential-resolved ECL systems was reviewed, which were classified, respectively, into three categories to be introduced in detail (inorganic, organic and nanomaterial-based ECL luminophores or potential-resolved ECL of metal–organic complexes, layer-by-layer-modified electrodes, and nanomaterials). On the other hand, we summarized ECL detection strategies based on potential-resolved ECL systems and the application of these protocols in disease biomarker detection, which results in two categories (self-calibration strategies and multi-target strategies) for discussion. In this work, we aim to inspire investigators to explore novel ECL luminophores and design detection strategies with high performance, which could provide strong support for precision medicine, personalized assessment, portable medical devices, and the digital transformation of healthcare.
Mechanical allodynia and hyperalgesia are intractable symptoms lacking effective clinical treatments in patients with neuropathic pain. However, whether and how mechanically responsive non-peptidergic nociceptors are involved remains elusive. Here, we showed that von Frey-evoked static allodynia and aversion, along with mechanical hyperalgesia after spared nerve injury (SNI) were reduced by ablation of MrgprdCreERT2-marked neurons. Electrophysiological recordings revealed that SNI-opened Aβ-fiber inputs to laminae I-IIo and vIIi, as well as C-fiber inputs to vIIi, were all attenuated in Mrgprd-ablated mice. In addition, priming chemogenetic or optogenetic activation of Mrgprd+ neurons drove mechanical allodynia and aversion to low-threshold mechanical stimuli, along with mechanical hyperalgesia. Mechanistically, gated Aβ and C inputs to vIIi were opened, potentially via central sensitization by dampening potassium currents. Altogether, we uncovered the involvement of Mrgprd+ nociceptors in nerve injury-induced mechanical pain and dissected the underlying spinal mechanisms, thus providing insights into potential therapeutic targets for pain management.